Literature DB >> 17576395

[Characterization of a Portuguese population with systemic lupus erytematosus].

M J Santos1, S Capela, R Figueira, P Nero, A Alves Matos, C Silva, L Miranda, A Barcelos, A Marques, A Teixeira, J Branco, J Canas da Silva, M Viana de Queiroz.   

Abstract

UNLABELLED: To characterize systemic lupus erythematosus (SLE) in Portuguese patients and to identify differences in diseases expression related to sex and ethnicity. PATIENTS AND METHODS: Retrospective cohort analysis of patients with SLE followed at five Rheumatology Departments between 1976 and 2006. Demographic data, diseases manifestations, medications used, co morbidity and damage scores were recorded.
RESULTS: Five hundred forty four patients were studied, 93% female, 89% Caucasians, with an average age at disease diagnosis of 35 years. The most frequent clinical features were musculoskeletal (91%), cutaneous and mucous membrane (90%) and the hematological involvement (58%). Renal diseases and serositis occurred more often in males while myositis was more common in black patients. Immunological features included the presence of anti-nuclear antibodies in 99% of the patients, anti-DNA (76%) anti-SSA (33%), anti-SSB (20%), anti-RNP (26%), anti-Sm (22%), anticardiolipine (31%) and lupus anticoagulant (21%). Anti-SSA, anti-RNP, and anti-Sm antibodies were significantly more prevalent among black patients. The presence and severity of damage measured by SLICC/ACR was similar between sexes and ethnicities. In multivariate analyses diseases duration and the presence of hypertension showed a positive association, while educational and antimalarials were negatively associated with the presence of damage.
CONCLUSION: In this cohort of Portuguese patients SLE present clinical features similar to those observed in other predominantly Caucasian populations, albeit a higher prevalence of anti-RNP and anti-Sm antibodies was observed. Some particular features were associated with male sex and African ethnicity. Some socio-demographic and clinical variables were associated with damage accrual.

Entities:  

Mesh:

Year:  2007        PMID: 17576395

Source DB:  PubMed          Journal:  Acta Reumatol Port        ISSN: 0303-464X            Impact factor:   1.290


  6 in total

1.  Interleukin-6 promoter polymorphism -174 G/C is associated with nephritis in Portuguese Caucasian systemic lupus erythematosus patients.

Authors:  Maria José Santos; Diana Fernandes; Susana Capela; Jose Canas da Silva; João Eurico Fonseca
Journal:  Clin Rheumatol       Date:  2010-12-14       Impact factor: 2.980

2.  Clinical features and long-term outcomes of systemic lupus erythematosus: comparative data of childhood, adult and late-onset disease in a national register.

Authors:  S Sousa; M J Gonçalves; L S Inês; G Eugénio; D Jesus; S Fernandes; G Terroso; V C Romão; M Cerqueira; A Raposo; M Couto; P Nero; G Sequeira; T Nóvoa; J A Melo Gomes; J Canas da Silva; L Costa; C Macieira; C Silva; J A P Silva; H Canhão; M J Santos
Journal:  Rheumatol Int       Date:  2016-03-15       Impact factor: 2.631

3.  Association of systemic lupus erythematosus clinical features with European population genetic substructure.

Authors:  Elisa Alonso-Perez; Marian Suarez-Gestal; Manuel Calaza; Torsten Witte; Chryssa Papasteriades; Maurizio Marchini; Sergio Migliaresi; Attila Kovacs; Josep Ordi-Ros; Marc Bijl; Maria Jose Santos; Sarka Ruzickova; Rudolf Pullmann; Patricia Carreira; Fotini N Skopouli; Sandra D'Alfonso; Gian Domenico Sebastiani; Ana Suarez; Francisco J Blanco; Juan J Gomez-Reino; Antonio Gonzalez
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

4.  Neuropsychiatric features of a cohort of patients with systemic lupus erythematosus.

Authors:  Maria Francisca Moraes-Fontes; Isabel Lúcio; Céu Santos; Maria Manuel Campos; Nuno Riso; Manuel Vaz Riscado
Journal:  ISRN Rheumatol       Date:  2012-11-20

5.  High frequency of Smith autoantibodies in Omani patients with systemic lupus erythematosus.

Authors:  Ali A Al-Jabri; Amal K Al-Gahdani; Ibtisam Al-Shuaili
Journal:  Rheumatol Int       Date:  2009-11       Impact factor: 3.580

Review 6.  Lupus Cohorts.

Authors:  Christopher Redmond; Omer Pamuk; Sarfaraz A Hasni
Journal:  Rheum Dis Clin North Am       Date:  2021-06-10       Impact factor: 2.032

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.